Earnings History Data for Panbela Therapeutics, Inc. (PBLA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Panbela Therapeutics, Inc.

Panbela Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing disruptive therapeutics for patients with urgent unmet medical needs. The company's initial product candidate, SBP-101, is for the treatment of patients with metastatic pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer. Panbela Therapeutics Inc., formerly known as Sun BioPharma Inc., is based in MINNEAPOLIS.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
10-11-2022 AH 4:10 PM ET
(Nov 10)
PBLA Panbela Therapeutics, Inc. 2.53 -0.21 -0.23 -0.16 Panbela Therapeutics GAAP EPS of -$0.21
[11/10/2022 4:19 PM]
0.1153 0.0 
(4.06%)
0.12 0.0 
(4.51%)
0.10 - 2.40 338,887 530,000 5,142
15-08-2022 AH 4:05 PM ET
(Aug 15)
PBLA Panbela Therapeutics, Inc. 28.46 -1.51 -0.22 -0.22 Panbela Therapeutics GAAP EPS of -$1.51
[8/15/2022 4:28 PM]
1.07 -0.12 
(-10.08%)
0.0 0.0 
(0.00%)
0.59 - 2.54 10,608 10,000 0
12-05-2022 AH 4:05 PM ET
(May 12)
PBLA Panbela Therapeutics, Inc. 22.19 -0.27 -0.26 -0.23 Panbela Therapeutics GAAP EPS of -$0.27
[5/12/2022 5:04 PM]
1.60 0.0 
(0.00%)
0.0 0.0 
(0.00%)
1.45 - 4.78 1,382 20,000 0
24-03-2022 AH 4:15 PM ET
(Mar 24)
PBLA Panbela Therapeutics, Inc. 25.54 -0.26 -0.19 -0.09 Panbela Therapeutics GAAP EPS of -$0.26
[3/24/2022 5:02 PM]
2.08 -0.03 
(-1.42%)
0.0 0.0 
(0.00%)
1.45 - 4.79 29,644 46,266 0
10-11-2021 AH 4:10 PM ET
(Nov 10)
PBLA Panbela Therapeutics, Inc. 28.47 -0.16 -0.27 -0.21 Panbela Therapeutics reports Q3 results
[11/10/2021 4:23 PM]
2.08 0.06 
(2.97%)
2.02 0.0 
(0.00%)
1.91 - 8.80 13,351 80,000 535
11-08-2021 AH 4:10 PM ET
(Aug 11)
PBLA Panbela Therapeutics, Inc. 32.76 -0.22 -0.23 0.00 Panbela Therapeutics reports Q2 results
[8/11/2021 4:20 PM]
2.32 -0.08 
(-3.33%)
2.39 -0.01 
(-0.42%)
2.22 - 9.75 239,929 500,000 6,375
12-05-2021 AH After the close
(May 12)
PBLA Panbela Therapeutics, Inc. 40.76 -0.23 0.00 0.00 Panbela Therapeutics reports Q1 results
[5/12/2021 4:18 PM]
3.85 -0.15 
(-3.83%)
4.17 0.01 
(0.24%)
2.37 - 10.00 19,569 40,000 200
25-03-2021 AH After the close
(Mar 25)
PBLA Panbela Therapeutics, Inc. 42.84 -0.09 0.00 0.00 Panbela Therapeutics reports Q4 results
[3/25/2021 4:58 PM]
4.23 0.03 
(0.71%)
4.10 -0.10 
(-2.38%)
2.37 - 10.00 13,036 20,000 10,086